Romidepsin in combination with low-dose methotrexate in advanced-stage mycosis fungoides and Sézary syndrome

Dermatol Ther. 2021 May;34(3):e14952. doi: 10.1111/dth.14952. Epub 2021 Mar 25.
No abstract available

Publication types

  • Letter

MeSH terms

  • Depsipeptides
  • Humans
  • Methotrexate / adverse effects
  • Mycosis Fungoides* / drug therapy
  • Sezary Syndrome* / drug therapy
  • Skin Neoplasms* / drug therapy

Substances

  • Depsipeptides
  • romidepsin
  • Methotrexate